Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Tom D who wrote (354)	12/9/1997 12:03:00 AM
From: scaram(o)uche	Respond to of 887

Tom: You mean that nothing much has happened to GLIA in the last two trading days? The last four is quite a different matter. Here's a snapshot of last week........ Depotech Corporation..... 14 3/4 22 1/4 11 1/8 -2.8% Gliatech Inc............. 12 7/8 14 3/8 7 5/8 +17.7% Fidelity Select Biotechno 36.98 39.98 28.32 +2.3% Franklin Global Health Ca 20.21 22.80 15.64 +0.8% AMEX Biotechnology Index. 170.53 +3.0% Dow Jones 30 Industrials. 8,149.13 +4.1% Let's hope that DEPO gets a similar kick in the next few days, but I really don't think that short-term jockeying is worth the effort (or necessarily prudent). Cheers! Rick

To: Tom D who wrote (354)	12/9/1997 1:07:00 AM
From: chirodoc	Respond to of 887

<<<<<<I really have no burning desire to take the money and run from DEPO. ........i was just thinking the same thing. with ODAC a likely shoe in we could see more than 4 analysts covering the stock. this increased coverage will steadily raise the price and interest--analysts love drug approvals and chemicals that have known risks and side effects--no surprises. ......i just hope that they get approval on the 18th. if they do--it doesn't matter what happens to the stock price between now and then. with their other ongoing trials and their accepted delivery system using well known molecules--sales should be steady with depocyte and then later their anti-biotics and analgesics--no need to convince the docs that the chemicals work---even great new drugs like rezulin, with a little bad publicity, can tear down the stock price. ...pray for approval!